loadpatents
name:-0.072664022445679
name:-0.050970077514648
name:-0.0081441402435303
Huang; Xianhai Patent Filings

Huang; Xianhai

Patent Applications and Registrations

Patent applications and USPTO patent grants for Huang; Xianhai.The latest application filed is for "novel substituted tricyclic compounds as indoleamine 2,3-dioxygenase inhibitors".

Company Profile
9.64.74
  • Huang; Xianhai - Warren NJ
  • Huang; Xianhai - Rahway NJ US
  • HUANG; Xianhai - US
  • Huang; Xianhai - Kenilworth NJ
  • Huang; Xianhai - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Chromane monobactam compounds for the treatment of bacterial infections
Grant 11,433,055 - Biftu , et al. September 6, 2
2022-09-06
Substituted [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors
Grant 11,352,320 - He , et al. June 7, 2
2022-06-07
Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
Grant 11,230,543 - Tang , et al. January 25, 2
2022-01-25
Novel Substituted Tricyclic Compounds As Indoleamine 2,3-dioxygenase Inhibitors
App 20210403469 - Han; Yongxin ;   et al.
2021-12-30
Novel [1.1.1] Bicyclo Compounds as Indoleamine 2,3-Dioxygenase Inhibitors
App 20210393600 - Guo; Liangqin ;   et al.
2021-12-23
Novel Aryloxypiperidine Pyrazole Compounds As Indoleamine 2,3-dioxygenase Inhibitors
App 20210330676 - Clausen; Dane ;   et al.
2021-10-28
Novel Substituted [1.1.1] Bicyclo Compounds As Indoleamine 2,3-dioxygenase Inhibitors
App 20210198190 - He; Shuwen ;   et al.
2021-07-01
Biaryl Monobactam Compounds And Methods Of Use Thereof For The Treatment Of Bacterial Infections
App 20200361928 - Tang; Haifeng ;   et al.
2020-11-19
Substituted aminoquinazoline compounds as A.sub.2A antagonist
Grant 10,822,338 - Ali , et al. November 3, 2
2020-11-03
Chromane Monobactam Compounds For The Treatment Of Bacterial Infections
App 20200297702 - Biftu; Tesfaye ;   et al.
2020-09-24
Compounds that are ERK inhibitors
Grant 10,759,805 - Lim , et al. Sep
2020-09-01
Tricyclic compounds as inhibitors of mutant IDH enzymes
Grant 10,442,819 - Fischer , et al. Oc
2019-10-15
Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections
Grant 10,407,421 - Liu , et al. Sept
2019-09-10
Tricyclic compounds as inhibitors of mutant IDH enzymes
Grant 10,399,972 - Witter , et al. Sep
2019-09-03
Bicyclic Aryl Monobactam Compounds And Methods Of Use Thereof For The Treatment Of Bacterial Infections
App 20190071436 - Liu; Weiguo ;   et al.
2019-03-07
Substituted Aminoquinazoline Compounds As A2a Antagonist
App 20180362530 - Ali; Amjad ;   et al.
2018-12-20
Biaryl Monobactam Compounds And Methods Of Use Thereof For The Treatment Of Bacterial Infections
App 20180339983 - Tang; Haifeng ;   et al.
2018-11-29
Novel Compounds That Are Erk Inhibitors
App 20180319804 - Lim; Jongwon ;   et al.
2018-11-08
Compounds that are ERK inhibitors
Grant 10,065,967 - Lim , et al. September 4, 2
2018-09-04
Nk 1 Antagonists
App 20180215729 - PALANI; Anandan ;   et al.
2018-08-02
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
Grant 10,011,615 - Ali , et al. July 3, 2
2018-07-03
ERK inhibitors
Grant 9,988,397 - Siliphaivanh , et al. June 5, 2
2018-06-05
NK.sub.1 antagonists
Grant 9,969,711 - Palani , et al. May 15, 2
2018-05-15
ERK inhibitors
Grant 9,884,048 - Siliphaivanh , et al. February 6, 2
2018-02-06
Novel Compounds That Are Erk Inhibitors
App 20170320882 - Lim; Jongwon ;   et al.
2017-11-09
Erk Inhibitors
App 20170267695 - Siliphaivanh; Phieng ;   et al.
2017-09-21
Erk Inhibitors
App 20170266167 - Siliphaivanh; Phieng ;   et al.
2017-09-21
Compounds that are ERK inhibitors
Grant 9,745,307 - Lim , et al. August 29, 2
2017-08-29
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20170197991 - Ali; Amjad ;   et al.
2017-07-13
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A.sub.2A antagonist properties
Grant 9,676,780 - Ali , et al. June 13, 2
2017-06-13
Nk 1 Antagonists
App 20170029403 - Palani; Anandan ;   et al.
2017-02-02
Quinoxalines and AZA-quinoxalines as CRTH.sub.2 receptor modulators
Grant 9,469,615 - Boyce , et al. October 18, 2
2016-10-18
NK.sub.1 antagonists
Grant 9,469,629 - Palani , et al. October 18, 2
2016-10-18
Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20160194330 - Ali; Amjad ;   et al.
2016-07-07
Substituted isoquinolines as CRTH2 receptor modulators
Grant 9,290,454 - Huang , et al. March 22, 2
2016-03-22
Novel Compounds That Are Erk Inhibitors
App 20160068532 - Lim; Jongwon ;   et al.
2016-03-10
Compounds that are ERK inhibitors
Grant 9,233,979 - Wilson , et al. January 12, 2
2016-01-12
Compounds that are ERK inhibitors
Grant 9,226,922 - Wilson , et al. January 5, 2
2016-01-05
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20150361098 - Ali; Amjad ;   et al.
2015-12-17
Substituted Isoquinolines As Crth2 Receptor Modulators
App 20150353498 - Huang; Xianhai ;   et al.
2015-12-10
Novel Compounds That Are Erk Inhibitors
App 20150266895 - Wilson; Kevin J. ;   et al.
2015-09-24
Novel Compounds That Are Erk Inhibitors
App 20150258074 - Wilson; Kevin J. ;   et al.
2015-09-17
Compounds that are ERK inhibitors
Grant 9,023,865 - Lim , et al. May 5, 2
2015-05-05
Quinazolinone-type compounds as CRTH.sub.2 antagonists
Grant 8,927,559 - Aslanian , et al. January 6, 2
2015-01-06
Nk1 Antagonists
App 20140296196 - Palani; Anandan ;   et al.
2014-10-02
Novel Compounds That Are Erk Inhibitors
App 20140296203 - Lim; Jongwon ;   et al.
2014-10-02
Gamma secretase modulators
Grant 8,809,318 - Zhu , et al. August 19, 2
2014-08-19
Gamma secretase modulators
Grant 8,759,337 - Asberom , et al. June 24, 2
2014-06-24
NK1 antagonists
Grant 8,754,216 - Shah , et al. June 17, 2
2014-06-17
Cycloalkyl-fused Tetrahydroquinolines As Crth2 Receptor Modulators
App 20140128367 - Huang; Xianhai ;   et al.
2014-05-08
Gamma secretase modulators
Grant 8,673,900 - Zhu , et al. March 18, 2
2014-03-18
Fused tricyclic compounds for the treatment of inflammatory disorders
Grant 8,598,158 - Xiao , et al. December 3, 2
2013-12-03
Cycloalkyl-fused tetrahydroquinolines as CRTH.sub.2 receptor modulators
Grant 8,592,383 - Huang , et al. November 26, 2
2013-11-26
Quinoxalines And Aza-quinoxalines As Crth2 Receptor Modulators
App 20130303517 - Boyce; Christopher W. ;   et al.
2013-11-14
Gamma secretase modulators
Grant 8,580,956 - Zhu , et al. November 12, 2
2013-11-12
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
Grant 8,569,312 - McCormick , et al. October 29, 2
2013-10-29
Biaryl-spiroaminooxzaoline Analogues As Alpha 2c Adrenergic Receptor Modulators
App 20130225582 - McCormick; Kevin D. ;   et al.
2013-08-29
Gamma secretase modulators
Grant 8,518,975 - Aslanian , et al. August 27, 2
2013-08-27
Gamma secretase modulators
Grant 8,487,099 - Greenlee , et al. July 16, 2
2013-07-16
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
Grant 8,476,274 - McCormick , et al. July 2, 2
2013-07-02
Gamma secretase modulators
Grant 8,450,343 - Huang , et al. May 28, 2
2013-05-28
Gamma secretase modulators
Grant 8,426,403 - Zhu , et al. April 23, 2
2013-04-23
Gamma secretase modulators
Grant 8,426,595 - Huang , et al. April 23, 2
2013-04-23
Reversed Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators
App 20130079271 - McCormick; Kevin D. ;   et al.
2013-03-28
Gamma secretase modulators
Grant 8,357,682 - Zhu , et al. January 22, 2
2013-01-22
Cycloalkyl-fused Tetrahydroquinolines As Crth2 Receptor Modulators
App 20120329743 - Huang; Xianhai ;   et al.
2012-12-27
Fused Tricyclic Compounds For The Treatment Of Inflammatory Disorders
App 20120316154 - Xiao; Dong ;   et al.
2012-12-13
Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators
Grant 8,324,213 - McCormick , et al. December 4, 2
2012-12-04
NK1 Antagonists
App 20120295879 - Palani; Anandan ;   et al.
2012-11-22
Gamma Secretase Modulators
App 20120245158 - Huang; Xianhai ;   et al.
2012-09-27
Gamma Secretase Modulators
App 20120238546 - Zhu; Zhaoning ;   et al.
2012-09-20
Gamma Secretase Modulators
App 20120232108 - Huang; Xianhai ;   et al.
2012-09-13
Gamma Secretase Modulators
App 20120107328 - Greenlee; William J. ;   et al.
2012-05-03
Gamma Secretase Modulators
App 20110306593 - Zhu; Zhaoning ;   et al.
2011-12-15
Gamma Secretase Modulators
App 20110294784 - Asberom; Theodros ;   et al.
2011-12-01
Gamma Secretase Modulators
App 20110294756 - Zhu; Zhaoning ;   et al.
2011-12-01
Gamma Secretase Modulators
App 20110257156 - Zhu; Zhaoning ;   et al.
2011-10-20
Biaryl-spiroaminooxazoline Analogues As Alpha 2c Adrenergic Receptor Modulators
App 20110251207 - McCormick; Kevin D. ;   et al.
2011-10-13
Bicyclic Pyranone Derivatives And Methods Of Use Thereof
App 20110243940 - Xiao; Dong ;   et al.
2011-10-06
NK.sub.1 antagonists
Grant 8,026,364 - Shah , et al. September 27, 2
2011-09-27
Nitrogen-containing Heterocyclic Compounds And Methods Of Use Thereof
App 20110152259 - Palani; Anandan ;   et al.
2011-06-23
Gamma Secretase Modulators
App 20110082153 - Aslanian; Robert G. ;   et al.
2011-04-07
Gamma Secretase Modulators
App 20110053918 - Zhu; Zhaoning ;   et al.
2011-03-03
Gamma Secretase Modulators For The Treatment Of Alzheimer's Disease
App 20110027264 - Huang; Xianhai ;   et al.
2011-02-03
Gamma Secretase Modulators
App 20110015190 - Huang; Xianhai ;   et al.
2011-01-20
Gamma Secretase Modulators
App 20110009392 - Zhu; Zhaoning ;   et al.
2011-01-13
Gamma Secretase Modulators
App 20100298372 - Huang; Xianhai ;   et al.
2010-11-25
Gamma Secretase Modulators
App 20100298359 - Huang; Xianhai ;   et al.
2010-11-25
Gamma Secretase Modulators
App 20100297128 - Huang; Xianhai ;   et al.
2010-11-25
Gamma Secretase Modulators
App 20100255005 - Zhu; Zhaoning ;   et al.
2010-10-07
Gamma Secretase Modulators
App 20100256128 - Zhu; Zhaoning ;   et al.
2010-10-07
Gamma Secretase Modulators
App 20100247514 - Zhu; Zhaoning ;   et al.
2010-09-30
Nitrogen-containing Heterocyclic Compounds And Methods Of Use Thereof
App 20100227873 - Palani; Anandan ;   et al.
2010-09-09
Nk 1 Antagonists
App 20100190759 - PALANI; Anandan ;   et al.
2010-07-29
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
Grant 7,763,623 - Palani , et al. July 27, 2
2010-07-27
Nitrogen-containing heterocyclic compounds and methods of use thereof
Grant 7,750,015 - Palani , et al. July 6, 2
2010-07-06
Nitrogen-containing heterocyclic compounds and methods of use thereof
Grant 7,737,155 - Palani , et al. June 15, 2
2010-06-15
Pyrimidinedione Derivatives And Methods Of Use Thereof
App 20100144764 - Huang; Xianhai ;   et al.
2010-06-10
Gamma Secretase Modulators
App 20100137320 - Huang; Xianhai ;   et al.
2010-06-03
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
Grant 7,723,342 - Palani , et al. May 25, 2
2010-05-25
NK1 antagonists
Grant 7,709,641 - Shah , et al. May 4, 2
2010-05-04
Bridged ring NK.sub.1 antagonists
Grant 7,354,922 - Xiao , et al. April 8, 2
2008-04-08
Nitrogen-containing Heterocyclic Compounds And Methods Of Use Thereof
App 20080019978 - Palani; Anandan ;   et al.
2008-01-24
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
App 20070173495 - Palani; Anandan ;   et al.
2007-07-26
Nitrogen-containing heterocyclic compounds and methods of use thereof
App 20070066630 - Palani; Anandan ;   et al.
2007-03-22
Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
App 20060264489 - Palani; Anandan ;   et al.
2006-11-23
Bridged ring NK1 antagonists
App 20060258665 - Xiao; Dong ;   et al.
2006-11-16
NK1 antagonists
App 20060223804 - Shah; Sapna S. ;   et al.
2006-10-05
Synthesis of non-symmetrical sulfamides using burgess-type reagents
Grant 7,015,321 - Nicolaou , et al. March 21, 2
2006-03-21
Synthesis of non-symmetrical sulfamides using burgess-type reagents
App 20040138448 - Nicolaou, Kyriacos C. ;   et al.
2004-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed